Nationwide Fund Advisors’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-90,991
| Closed | -$409K | – | 2721 |
|
|
2017
Q3 | $409K | Sell |
90,991
-2,452
| -3% | -$11K | ﹤0.01% | 2282 |
|
|
2017
Q2 | $429K | Buy |
93,443
+12,303
| +15% | +$56.5K | ﹤0.01% | 2263 |
|
|
2017
Q1 | $342K | Sell |
81,140
-5,139
| -6% | -$21.7K | ﹤0.01% | 2360 |
|
|
2016
Q4 | $356K | Buy |
86,279
+9,112
| +12% | +$37.6K | ﹤0.01% | 2350 |
|
|
2016
Q3 | $625K | Hold |
77,167
| – | – | ﹤0.01% | 2064 |
|
|
2016
Q2 | $602K | Buy |
77,167
+1,606
| +2% | +$12.5K | ﹤0.01% | 2054 |
|
|
2016
Q1 | $599K | Sell |
75,561
-34,809
| -32% | -$276K | ﹤0.01% | 1994 |
|
|
2015
Q4 | $1.19M | Sell |
110,370
-6,587
| -6% | -$71.1K | 0.01% | 1640 |
|
|
2015
Q3 | $808K | Buy |
116,957
+6,380
| +6% | +$44.1K | ﹤0.01% | 1838 |
|
|
2015
Q2 | $980K | Sell |
110,577
-233,425
| -68% | -$2.07M | ﹤0.01% | 1871 |
|
|
2015
Q1 | $3.39M | Buy |
344,002
+270,441
| +368% | +$2.67M | 0.01% | 1175 |
|
|
2014
Q4 | $901K | Sell |
73,561
-990
| -1% | -$12.1K | ﹤0.01% | 1864 |
|
|
2014
Q3 | $744K | Sell |
74,551
-75
| -0.1% | -$748 | ﹤0.01% | 1977 |
|
|
2014
Q2 | $565K | Buy |
74,626
+559
| +0.8% | +$4.23K | ﹤0.01% | 2194 |
|
|
2014
Q1 | $244K | Sell |
74,067
-1,012
| -1% | -$3.33K | ﹤0.01% | 2400 |
|
|
2013
Q4 | $249K | Sell |
75,079
-156,276
| -68% | -$518K | ﹤0.01% | 2585 |
|
|
2013
Q3 | $699K | Sell |
231,355
-70,324
| -23% | -$212K | ﹤0.01% | 2043 |
|
|
2013
Q2 | $2.47M | Buy |
+301,679
| New | +$2.47M | 0.01% | 1176 |
|